Market Overview:
The global in vitro toxicology testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for in vitro toxicology testing services from pharmaceuticals & biopharmaceuticals industry, cosmetics and household products industry, food industry, and chemicals industry. In addition, technological advancements in cell culture technology, high-throughput technology, cellular imaging technology, and toxicogenomics are also contributing to the growth of the global in vitro toxicology testing market. However, lack of skilled professionals is restraining the growth of this market. On the basis of type, the global in vitro toxicology testing market can be segmented into cell culture technology, high-throughput technology,, cellular imaging technology,, and toxigenomics.
Product Definition:
In vitro toxicology testing is the study of the effects of chemical substances on cells or tissues in a laboratory setting. The importance of in vitro toxicology testing is that it can help identify potential hazards associated with new chemicals before they are released into the environment.
Cell Culture Technology:
Cell culture technology is a set of procedures used to grow and study cells in a controlled environment. It helps in the production of cell-based models for drug development, toxicology testing, and other research purposes.
High-throughput Technology:
High-throughput technology is a method used to increase the throughput or volume of tests in toxicology studies. It helps overcome the limitations of conventional testing by speeding up and simplifying procedures, while maintaining accuracy.
The advantages associated with this technology are increased efficiency, cost-effectiveness, and better use of laboratory resources. The major advantage is that it reduces the time required for conducting various toxicity assays as compared to conventional methods which thereby increases its adoption rate globally.
Application Insights:
The global in vitro toxicology testing market is segmented on the basis of application into pharmaceuticals & biopharmaceuticals industry, cosmetics and household products industry, food industry, chemicals industry and others. The pharmaceutical and biopharmaceutical sector dominated the overall market accounting for over 40% of the revenue share in 2017. This is due to a large number of drug candidates undergoing pre-clinical toxicity studies before they are introduced into clinical trials. In addition, an increasing number of product launches by major companies such as Pfizer Inc., Johnson & Johnson (J&J), Merck KGaA, Novartis AG et al. accounts for a significant share in this segment.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a well-established regulatory framework for drug approval, extensive R&D activities by major companies, and high adoption of advanced technologies across this region. Moreover, increasing cases of chronic diseases due to unhealthy lifestyles are expected to drive demand for toxicology testing services in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by various governments as well as private organizations and an increase in disposable income that has led people from lower socio-economic backgrounds seeking medical assistance resulting into an increased demand for toxicology testing services within this region.
Growth Factors:
- Increasing demand for In Vitro Toxicology Testing from the pharmaceutical and biotechnology industries to assess the safety of new drug candidates
- Growing number of public and private sector initiatives to promote In Vitro Toxicology Testing as a key tool for assessing environmental toxicity
- Rising awareness about the benefits of In Vitro Toxicology Testing among researchers and regulatory agencies worldwide
- Proliferation of novel in vitro assay technologies that facilitate more accurate and rapid testing for toxicity
- Increasing investment in research and development on In Vitro Toxicology Testing by leading players in the market
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Toxicology Testing Market Research Report
By Type
Cell Culture Technology, High-throughput Technology, Cellular Imaging Technology, Toxicogenomics
By Application
Pharmaceuticals & Biopharmaceuticals Industry, Cosmetics and Household Products Industry, Food Industry, Chemicals Industry
By Companies
SGS, Covance, Bio-Rad Laboratories, Qiagen, GE Healthcare, Eurofins Scientific, Merck, Thermo Fisher, Charles River Laboratories International, Catalent, Cyprotex, Promega, Gentronix Limited, Ascendance Biotechnology, MB Research Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro Toxicology Testing Market Report Segments:
The global In Vitro Toxicology Testing market is segmented on the basis of:
Types
Cell Culture Technology, High-throughput Technology, Cellular Imaging Technology, Toxicogenomics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceuticals & Biopharmaceuticals Industry, Cosmetics and Household Products Industry, Food Industry, Chemicals Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SGS
- Covance
- Bio-Rad Laboratories
- Qiagen
- GE Healthcare
- Eurofins Scientific
- Merck
- Thermo Fisher
- Charles River Laboratories International
- Catalent
- Cyprotex
- Promega
- Gentronix Limited
- Ascendance Biotechnology
- MB Research Laboratories
Highlights of The In Vitro Toxicology Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Culture Technology
- High-throughput Technology
- Cellular Imaging Technology
- Toxicogenomics
- By Application:
- Pharmaceuticals & Biopharmaceuticals Industry
- Cosmetics and Household Products Industry
- Food Industry
- Chemicals Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Toxicology Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In Vitro Toxicology Testing is a process that evaluates the toxicity of chemicals in vitro. This means that the chemicals are tested on cells or tissues in a laboratory setting, rather than being tested on animals.
Some of the key players operating in the in vitro toxicology testing market are SGS, Covance, Bio-Rad Laboratories, Qiagen, GE Healthcare, Eurofins Scientific, Merck, Thermo Fisher, Charles River Laboratories International, Catalent, Cyprotex, Promega, Gentronix Limited, Ascendance Biotechnology, MB Research Laboratories.
The in vitro toxicology testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vitro Toxicology Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In Vitro Toxicology Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In Vitro Toxicology Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In Vitro Toxicology Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In Vitro Toxicology Testing Market Size & Forecast, 2018-2028
4.5.1 In Vitro Toxicology Testing Market Size and Y-o-Y Growth
4.5.2 In Vitro Toxicology Testing Market Absolute $ Opportunity
Chapter 5 Global In Vitro Toxicology Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 In Vitro Toxicology Testing Market Size Forecast by Type
5.2.1 Cell Culture Technology
5.2.2 High-throughput Technology
5.2.3 Cellular Imaging Technology
5.2.4 Toxicogenomics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global In Vitro Toxicology Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 In Vitro Toxicology Testing Market Size Forecast by Applications
6.2.1 Pharmaceuticals & Biopharmaceuticals Industry
6.2.2 Cosmetics and Household Products Industry
6.2.3 Food Industry
6.2.4 Chemicals Industry
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vitro Toxicology Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vitro Toxicology Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America In Vitro Toxicology Testing Analysis and Forecast
9.1 Introduction
9.2 North America In Vitro Toxicology Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America In Vitro Toxicology Testing Market Size Forecast by Type
9.6.1 Cell Culture Technology
9.6.2 High-throughput Technology
9.6.3 Cellular Imaging Technology
9.6.4 Toxicogenomics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America In Vitro Toxicology Testing Market Size Forecast by Applications
9.10.1 Pharmaceuticals & Biopharmaceuticals Industry
9.10.2 Cosmetics and Household Products Industry
9.10.3 Food Industry
9.10.4 Chemicals Industry
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe In Vitro Toxicology Testing Analysis and Forecast
10.1 Introduction
10.2 Europe In Vitro Toxicology Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe In Vitro Toxicology Testing Market Size Forecast by Type
10.6.1 Cell Culture Technology
10.6.2 High-throughput Technology
10.6.3 Cellular Imaging Technology
10.6.4 Toxicogenomics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe In Vitro Toxicology Testing Market Size Forecast by Applications
10.10.1 Pharmaceuticals & Biopharmaceuticals Industry
10.10.2 Cosmetics and Household Products Industry
10.10.3 Food Industry
10.10.4 Chemicals Industry
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific In Vitro Toxicology Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific In Vitro Toxicology Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific In Vitro Toxicology Testing Market Size Forecast by Type
11.6.1 Cell Culture Technology
11.6.2 High-throughput Technology
11.6.3 Cellular Imaging Technology
11.6.4 Toxicogenomics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific In Vitro Toxicology Testing Market Size Forecast by Applications
11.10.1 Pharmaceuticals & Biopharmaceuticals Industry
11.10.2 Cosmetics and Household Products Industry
11.10.3 Food Industry
11.10.4 Chemicals Industry
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America In Vitro Toxicology Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America In Vitro Toxicology Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America In Vitro Toxicology Testing Market Size Forecast by Type
12.6.1 Cell Culture Technology
12.6.2 High-throughput Technology
12.6.3 Cellular Imaging Technology
12.6.4 Toxicogenomics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America In Vitro Toxicology Testing Market Size Forecast by Applications
12.10.1 Pharmaceuticals & Biopharmaceuticals Industry
12.10.2 Cosmetics and Household Products Industry
12.10.3 Food Industry
12.10.4 Chemicals Industry
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) In Vitro Toxicology Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) In Vitro Toxicology Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) In Vitro Toxicology Testing Market Size Forecast by Type
13.6.1 Cell Culture Technology
13.6.2 High-throughput Technology
13.6.3 Cellular Imaging Technology
13.6.4 Toxicogenomics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) In Vitro Toxicology Testing Market Size Forecast by Applications
13.10.1 Pharmaceuticals & Biopharmaceuticals Industry
13.10.2 Cosmetics and Household Products Industry
13.10.3 Food Industry
13.10.4 Chemicals Industry
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vitro Toxicology Testing Market: Competitive Dashboard
14.2 Global In Vitro Toxicology Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SGS
14.3.2 Covance
14.3.3 Bio-Rad Laboratories
14.3.4 Qiagen
14.3.5 GE Healthcare
14.3.6 Eurofins Scientific
14.3.7 Merck
14.3.8 Thermo Fisher
14.3.9 Charles River Laboratories International
14.3.10 Catalent
14.3.11 Cyprotex
14.3.12 Promega
14.3.13 Gentronix Limited
14.3.14 Ascendance Biotechnology
14.3.15 MB Research Laboratories
